IM-VIT100

Completed Study

A safety and efficacy assessment of chimeric ribosyme to proliferating cell nuclear antigen to prevent recurrence of proliferative vitreoretinopathy.

Return to Sub-studies

Connect

Loading ...

Ophthalmologist Website Design | Accessibility Policy
Washington DC IM-VIT100 | Chimeric Ribosyme Assessment in Maryland | Virginia IM-VIT100